RxDoctor Payments Data

Peter Luea, MD

Family Medicine · Lansing, MINPI 1780639880

Payments from drug & device makers

$4,559in general payments, 2019–2025

Across 271 payments — averaging $16.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$669
  • Novo Nordisk$525
  • Amgen$460
  • Pfizer$381
  • GSK$367
  • Amarin Pharma, Inc.$207
  • plus $2K from 36 others

What the payments were for

  • Food & beverage$4,545100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,559 in reported general payments places this provider in the 90th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$40,956
Medicare patients
107
Services billed
603

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tasimelteon12$246,038
MounjaroTirzepatide50$65,114
EliquisApixaban41$54,462
Trelegy ElliptaFluticasone/Umeclidin/Vilanter35$35,883
TrulicityDulaglutide28$34,846
JanuviaSitagliptin Phosphate22$31,500
JardianceEmpagliflozin23$29,601
OzempicSemaglutide22$28,303
XareltoRivaroxaban12$15,370
LinzessLinaclotide17$15,094
OxycontinOxycodone Hcl16$13,533
JanumetSitagliptin Phos/Metformin Hcl13$8,182
Colesevelam Hcl20$7,122
TrintellixVortioxetine Hydrobromide12$5,508
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$5,253

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$169$99,96078 claims
PfizerEliquis$381$54,46241 claims
MerckJanuvia, Janumet$72$39,68235 claims
GSKTrelegy Ellipta$367$35,88335 claims
Boehringer IngelheimJardiance$178$29,60123 claims
Novo NordiskOzempic$525$28,30322 claims
AbbVieLinzess, Synthroid$669$16,40833 claims
Johnson & JohnsonXarelto$30$15,37012 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$30$5,50812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Lansing

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →